Background The purpose of this study was to assess genital recurrence of human
papillomavirus (HPV) genotypes included in the 9-valent vaccine and to investigate factors …

Background. In this analysis, we examine the incidence and clearance of external genital
human papillomavirus (HPV) infection among heterosexual males aged 16–24 years …

Background. The purpose of this study was to assess the risk of sequential acquisition of
anal human papillomavirus (HPV) infection following a type-specific genital HPV infection for …

Background: Few human papillomavirus (HPV) serology studies have evaluated type-
specific seroprevalence of vaccine HPV types in men. This study investigates …

Background. Little is known about type-specific associations between prevalent human
papillomavirus (HPV) infections and risk of acquiring other HPV types in men. Data on …

Background Human papillomavirus (HPV) infection is estimated to be the most common
sexually transmitted infection; an estimated 6.2 million persons are newly infected every …

Background In Australia, high uptake of the quadrivalent human papillomavirus (4vHPV)
vaccine has led to reductions in the prevalence of human papillomavirus (HPV) genotypes …

Background International data on anogenital HPV infection incidence among men are
limited. Methods Incidence of incident-persistent (IP) anogenital HPV infections was …

Background. We report the first nationally representative prevalence data on genital human
papillomavirus (HPV) in males in the United States, using findings from the National Health …

Background Human papillomavirus (HPV) is one of the most common sexually transmitted
infections worldwide. Recently a 9-valent HPV (9vHPV) prophylactic vaccine was licensed …